Histofi, Inc. Employee Directory
Hospitals and Health CareCalifornia, United States2-10 Employees
The use of AI/ML technology significantly enhances early cancer detection, diagnostic accuracy, and patient outcomes by accelerating Time-to-Treatment Initiation (TTI). Providers in underserved areas face barriers to adopt novel cancer care technologies due to high costs and tech-complexity, resulting in access inequities. We removed these barriers by offering MedTech Value-Added Solution (mtVAS) Platform-as-a-Service (PaaS). The mtVAS-PaaS equips our users with AI/ML-driven tools to detect cancer early and personalize treatment, achieving optimal outcomes.